home / stock / otlc / otlc news

OTLC News and Press, Oncotelic Therapeutics Inc From 04/17/23

Stock Information
Company Name: Oncotelic Therapeutics Inc
Stock Symbol: OTLC
Market: OTC
Website: oncotelic.com
Menu
OTLC OTLC Quote OTLC Short OTLC News OTLC Articles OTLC Message Board
Get OTLC Alerts

News, Short Squeeze, Breakout and More Instantly...
OTLC - ONCOTELIC PROVIDES YE 2022 FINANCIAL RESULTS COMPARED TO YE 2021 PRODUCT DEVELOPMENT INITIATIVES AND CORPORATE UPDATE

AGOURA HILLS, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“ Oncotelic ” , “ We ” or the “ Company ”) ( OTCQB: OTLC ) is providing a summary of its financial results...
OTLC - Oncotelic Announces Release of Pet2DAO Tokens (PDAO)

AGOURA HILLS, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's Disease, Pancreatic Ductal Adenocarcinoma, Diffuse Intrinsic Pontine Glioma, and...

OTLC - Oncotelic Announces Pet2DAO Website is Live

PDAO is to Revolutionize Decentralized Autonomous Organization AGOURA HILLS, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a clinical stage biotechnology company, today announced the launch of its Pet2DAO webs...

OTLC - High Intra-Tumor TGF-?2 Predicts Poor Survival in Pediatric Cancer of the Brainstem

-The TGFβ1 and TGFβ3 isoforms are predictive --Validation of TGFβ 2 as therapeutic target AGOURA HILLS, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments ...
OTLC - Oncotelic Announces Initiation of Clinical Study in Non-Small Lung Cell Cancer

AGOURA HILLS, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's Disease, PDAC, DIPG, and COVID-19, today announced the initiation of its second i...

OTLC - Oncotelic Initiates Clinical Trials Evaluating OT-101 against Metastatic Pancreatic Cancer

AGOURA HILLS, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a clinical stage biotechnology company, with a planned IPO of its JV this year, today announced that it has submitted a clinical study protocol to the US Food and...

OTLC - Oncotelic Announces the launch of PDAO token

- PDAO is to Revolutionize Decentralized Autonomous Organization (DAO) AGOURA HILLS, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a clinical stage biotechnology company, with a planned IPO of its JV this yea...
OTLC - Oncotelic Issues Year End Message to Shareholders

– JV continues to advance to its IPO - OT-101 immunotherapy expanding with at least 10 planned IIS clinical trials for 2023 - OT-101 commercialization effort expanding on multiple fronts - M anufacturing and DAO capabili...

OTLC - Oncotelic Presents Clinical Data of Confirming TGF-?2 as the appropriate target for gliomas at JCA-AACR Meeting 2022

- Reduced TGF-β2, but not TGF-β1 nor TGF-β3, is associated with improved OS. AGOURA HILLS, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a clinical stage biotechnology company, to...

OTLC - Oncotelic Publishes SNO 27th Annual Meeting Presentation Materials

AGOURA HILLS, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's Disease, PDAC, DIPG, and COVID-19, today announced the publication of the present...
Previous 10 Next 10